Critical need for appropriate mucosal sample collection to determine relational animal pharmacokinetic-pharmacodynamic models in HIV prevention

AIDS Res Hum Retroviruses. 2013 Nov;29(11):1398-400. doi: 10.1089/AID.2013.0142. Epub 2013 Aug 30.

Authors

Leslie Marshall¹, James Cummins, Hans Spiegel, James Turpin, Fulvia Veronese, Angela Kashuba; HIV Prevention Pharmacology Best Practices Working Group

Affiliation

¹ 1 Preclinical Microbicide and Prevention Research Branch, Prevention Sciences Program, Division of AIDS, National Institute of Allergy and Infectious Disease, National Institutes of Health , Bethesda, Maryland.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Animals
Anti-HIV Agents / administration & dosage
Anti-HIV Agents / pharmacokinetics*
Anti-HIV Agents / pharmacology*
HIV Infections / drug therapy*
HIV Infections / prevention & control*
Humans
Models, Animal*
Mucous Membrane / chemistry*

Substances

Anti-HIV Agents